The detection of G6PD enzyme activity is consistent with the protein expression level, suggesting that FRA1 can inhibit the PPP bypass of cervical cancer cells, while LPS can negatively regulate the inhibition of FRA1 and restore the PPP bypass level of cervical cancer cells. The gene discussed is FOSL1; the disease is cervical carcinoma.